Further recontact regarding risk-reducing bilateral salpingo-oophorectomy (RRBSO) should occur at different ages depending on gene-specific ovarian cancer risk: 35–40 years (BRCA1) and 40–45 years (BRCA2). This evidence concerns the gene BRCA2 and ovarian carcinoma.